Focal adhesion kinase as a target in the treatment of hematological malignancies
Author:
- 1 October 2011
- journal article
- review article
- Published by Elsevier in Leukemia Research
- Vol. 35 (10) , 1416-1418
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Focal adhesion kinase and p53 signal transduction pathways in cancerFrontiers in Bioscience-Landmark, 2010
- Focal adhesion kinase (FAK) expression in normal and neoplastic lymphoid tissuesPathology - Research and Practice, 2009
- Focal Adhesion Kinase Targeting UsingIn vivoShort Interfering RNA Delivery in Neutral Liposomes for Ovarian Carcinoma TherapyClinical Cancer Research, 2006
- Intrinsic FAK activity and Y925 phosphorylation facilitate an angiogenic switch in tumorsOncogene, 2006
- Focal Adhesion Kinase Suppresses Apoptosis by Binding to the Death Domain of Receptor-Interacting ProteinMolecular and Cellular Biology, 2004
- Cloning and characterization of the promoter region of human focal adhesion kinase gene: nuclear factor kappa B and p53 binding sitesBiochimica et Biophysica Acta (BBA) - Gene Structure and Expression, 2004
- Focal adhesion kinase: the first ten yearsJournal of Cell Science, 2003
- Antiapoptotic Action of Focal Adhesion Kinase (FAK) Against Ionizing RadiationAntioxidants & Redox Signaling, 2002
- Anti-apoptotic Role of Focal Adhesion Kinase (FAK)Journal of Biological Chemistry, 2000
- Control of adhesion-dependent cell survival by focal adhesion kinase.Journal of Cell Biology, 1996